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Introduction
Recent studies showed a notable frequency of somatic
mosaicism of the NLRP3 gene in chronic, infantile, neu-
rological, cutaneous and articular (CINCA) syndrome
(35%) and Muckle-Wells syndrome (MWS)(12.5%)
patients that were not detectable by common Sanger
sequencing.
Objectives
We are currently trying to detect and quantify low fre-
quency NLRP3 variants in mutation-negative patients,
who suffer from a CINCA Syndrome, MWS or Familial
Cold Autoinflammatory Syndrome (FCAS) or show
cryopyrin-associated periodic syndrome (CAPS)-like
symptoms without a classical phenotype.
Methods
The exons of the NLRP3 gene were amplified via PCR
from genomic PBMC DNA. The obtained PCR products
were sequenced with an Illumina HiSeq platform. For
SNP calling we used the GATK pipeline of the 1000
Genome Project, if the coverage attained 40,000 fold. In
order to prove the accuracy of the method, we quanti-
fied dilutions of a known heterozygous mutation
(T348M) mixed with wildtype DNA. For the correlation
between the test results and the phenotype of the
patients we developed a survey including symptoms and
medical treatment.
Results
In one CINCA patient we detected a new NLRP3 variant
(L359S) in 30% of the sequence. Using a cut-off of 5%
mutated DNA sequences, we did not detect any other
mutation of the NLRP3 gene in the other 47 samples we
tested so far. We tried to increase the sensitivity by
establishing a new statistic method (M+2SD), setting the
cut-off at 0.5%. This led to a drastic reduction of specifi-
city with irreproducible results.
Conclusion
Massive parallel sequencing is a reliable method for the
quantification of low frequency variants of the NLRP3
gene. Increasing the sensitivity (<5% cut-off) results in
detecting PCR artifacts and a dramatic loss of specificity.
The probability of somatic mosaicism in mutation-nega-
tive CAPS patients is higher if the symptoms are more
severe. Although 35% of mutation-negative CINCA
patients and 12.5% of mutation-negative MWS patients
harbor somatic mutations, this seems to be extremely
rare in patients with CAPS-like symptoms without clas-
sical CAPS phenotype.
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